R.S. Drugs And Medicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 16-07-2024
- Paid Up Capital ₹ 6.00 M
as on 16-07-2024
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.00 Cr
as on 16-07-2024
- Satisfied Charges ₹ 7.00 Cr
as on 16-07-2024
- Revenue 15.85%
(FY 2023)
- Profit 27.32%
(FY 2023)
- Ebitda 19.08%
(FY 2023)
- Net Worth 25.47%
(FY 2023)
- Total Assets 24.49%
(FY 2023)
About R.S. Drugs And Medicals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 6.00 M.
The company currently has active open charges totaling ₹8.00 Cr. The company has closed loans amounting to ₹7.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mahalingam Sathish, Jayaseelan Pichamuthu, Shivanandhini Jayaseelan, and One other member serve as directors at the Company.
- CIN/LLPIN
U51909TN2017PTC116117
- Company No.
116117
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Apr 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at R.S. Drugs And Medicals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahalingam Sathish  | Additional Director | 01-Jun-2017 | Current |
| Jayaseelan Pichamuthu | Additional Director | 01-Jun-2017 | Current |
| Shivanandhini Jayaseelan | Director | 19-Feb-2018 | Current |
| Vijaya Bharathi | Director | 19-Feb-2018 | Current |
Financial Performance of R.S. Drugs And Medicals.
R.S. Drugs And Medicals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.85% increase. The company also saw a substantial improvement in profitability, with a 27.32% increase in profit. The company's net worth Soared by an impressive increase of 25.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of R.S. Drugs And Medicals?
In 2022, R.S. Drugs And Medicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Prakas Pharmacy Private LimitedActive 12 years 2 daysMahalingam Sathish and Jayaseelan Pichamuthu are mutual person
Jandv Pharmacy Private LimitedActive 5 years 1 monthJayaseelan Pichamuthu, Shivanandhini Jayaseelan and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 09 Apr 2018 | ₹8.00 Cr | Open |
Axis Bank Limited Creation Date: 24 Jul 2017 | ₹7.00 Cr | Satisfied |
How Many Employees Work at R.S. Drugs And Medicals?
R.S. Drugs And Medicals has a workforce of 27 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of R.S. Drugs And Medicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped R.S. Drugs And Medicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
